393
Participants
Start Date
October 31, 2016
Primary Completion Date
September 22, 2017
Study Completion Date
October 7, 2020
Viaskin Peanut 250 mcg
Placebo
Mount Sinai Medical Center, New York
Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Johns Hopkins Hospital, Baltimore
The University of North Carolina - Chapell Hill, Chapel Hill
National Allergy and Asthma Research, Charleston
Atlanta Allergy & Asthma Clinic, Marietta
Sarasota Clinical Research, Sarasota
Clinical Research Institute, Plymouth
Ann & Robert H. Lurie Children's Hospital of CHicago, Chicago
Sneeze, Wheeze and Itch Associates,Clinical Research, Normal
Children's Mercy Hospital, Kansas City
The Asthma and Allergy Center, Bellevue
Arkansas Children's Hospital, Little Rock
Baylor College of Medicine - Texas Children's Hospital, Houston
Sylvana Research, San Antonio
STAAMP Research, San Antonio
Children's Hospital Colorado, Aurora
National Jewish Health, Denver
Palos Verdes Medical Group, Rolling Hills Estates
Allergy & Asthma Associates of Southern California, Mission Viejo
Stanford University School of Medicine, Stanford
Massachusetts General Hospital, Boston
Boston Childrens' Hospital, Boston
Children's Medical Center of Dallas, Dallas
ASTHMA, Inc. Clinical Research, Seattle
Children's and Women's Health Centre of Brisith Columbia, Vancouver
Alpha Medical Research Inc., Mississauga
Ottawa Allergy Asthma Research Institute, Ottawa
Gordon Sussman Clinical Research Inc., Toronto
Centre Hospitalier Universitaire Sainte Justine, Montreal
Centre De Recherche Applique, Québec
Lead Sponsor
DBV Technologies
INDUSTRY